NYSE · Healthcare100% Authentic Upstream Feed (MR-007)

Eli Lilly And Co (LLY)

Real-time institutional stock price, dual quantitative model evaluation (4-Factor Quant Rank + 6-Factor Fundamental Composite), valuation multiples, and forensic accounting audit.

Live Authentic Market Price
$1427.82
$-4.45 (-0.31%)
Vol: 736,560
Market Capitalization$1340.00B
P/E Multiple (TTM)—
52-Week Range$850.51 – $1449.68
Beta / Volatility0.40
Model A · Equal-Weight 25%

4-Factor Quant Rank

#207
Percentile Score:71.3 / 100
Valuation Percentile:25.0
Growth Percentile:96.3
Business Quality Percentile:98.7
Momentum Percentile:65.1
Cross-sectional universe comparison across 2,714 U.S. equities (Official v2.1).
Model B · Fundamental Pillars

6-Factor Fundamental Rating

Evaluation Pending
Fundamental Score:
Pending
Valuation:—
Growth:—
Profitability:—
Financial Health:—
EPS Revisions:—
Dividend Quality:—
Absolute balance sheet health and SEC Edgar filing verification.

Source-Backed Financial Highlights

SEC EDGAR & Market Data Lineage
Revenue (TTM)—
Diluted EPS—
Forward P/E—
Price to Sales—
Operating Margin—
Net Margin—

Institutional Peer Comparison Cohort

Direct sector comparables for Eli Lilly And Co in Healthcare

4-Factor Quant Benchmarks
NVONVO Common Stock
Compare→
MRKMRK Common Stock
Compare→
ABBVAbbVie Inc.
Compare→
PFEPFE Common Stock
Compare→
JNJJohnson & Johnson
Compare→